Bridgeworth’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$375K Sell
1,386
-39
-3% -$9.64K 0.04% 124
2023
Q3
$351K Hold
1,425
0.04% 117
2023
Q2
$432K Buy
1,425
+3
+0.2% +$834 0.05% 110
2023
Q1
$375K Hold
1,422
0.05% 110
2022
Q4
$341K Sell
1,422
-20
-1% -$4.48K 0.05% 113
2022
Q3
$265K Hold
1,442
0.06% 115
2022
Q2
$242K Hold
1,442
0.06% 124
2022
Q1
$361K Hold
1,442
0.08% 103
2021
Q4
$370K Sell
1,442
-481
-25% -$118K 0.08% 107
2021
Q3
$467K Hold
1,923
0.13% 81
2021
Q2
$398K Buy
1,923
+422
+28% +$86K 0.11% 92
2021
Q1
$283K Hold
1,501
0.09% 100
2020
Q4
$247K Sell
1,501
-117
-7% -$17.1K 0.08% 106
2020
Q3
$202K Buy
+1,618
New +$200K 0.08% 117
2020
Q1
Sell
-1,618
Closed -$239K 129
2019
Q4
$239K Buy
+1,618
New +$217K 0.09% 115
2019
Q3
Sell
-1,618
Closed -$219K 134
2019
Q2
$219K Sell
1,618
-76
-4% -$9.61K 0.08% 118
2019
Q1
$221K Hold
1,694
0.09% 119
2018
Q4
$211K Hold
1,694
0.12% 112
2018
Q3
$238K Hold
1,694
0.13% 108
2018
Q2
$173K Buy
+1,694
New +$171K 0.07% 147

Other funds holding HCA

Bridgeworth's HCA Position: Q4 2023 in Review

Bridgeworth reduced its HCA Healthcare (HCA) stake by 2.7% in Q4 2023, selling an estimated $9.64K and leaving 1,386 shares worth $375K. The position accounts for 0.04% of the portfolio, ranked #124.

Bridgeworth first reported a position in HCA in Q2 2018 and has held it in 20 quarters since. The position peaked at $467K in Q3 2021. 1,056 funds tracked by Wall St. Rank hold HCA as of Q4 2023.

  • Bridgeworth held 1,386 shares of HCA Healthcare worth $375K as of Q4 2023.
  • Bridgeworth sold 39 HCA Healthcare shares in Q4 2023, an estimated $9.64K.
  • HCA Healthcare made up 0.04% of Bridgeworth's portfolio in Q4 2023, its #124 holding.
  • Bridgeworth first reported a position in HCA Healthcare in Q2 2018 and has held it in 20 quarters since.
  • Bridgeworth's HCA Healthcare position peaked at $467K in Q3 2021.
  • 1,056 funds tracked by Wall St. Rank held HCA Healthcare as of Q4 2023.

Based on Bridgeworth's 13F filing for Q4 2023, filed 26 Jan 2024.